<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">KJIM</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Internal Medicine</journal-title><abbrev-journal-title>Korean J Intern Med</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">1226-3303</issn>
<issn pub-type="epub">2005-6648</issn>
<publisher>
<publisher-name>The Korean Association of Internal Medicine</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3904/kjim.2016.423</article-id>
<article-id pub-id-type="publisher-id">kjim-2016-423</article-id>
<article-categories>
<subj-group>
<subject>Image of interest</subject></subj-group></article-categories>
<title-group>
<article-title>Painful nodule on umbilicus: Sister Mary Joseph nodule as an unusual but important manifestation of widespread gallbladder cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Hong Ja</given-names></name>
<xref ref-type="corresp" rid="c1-kjim-2016-423"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yong</surname><given-names>Ho Jin</given-names></name>
</contrib>
<aff id="af1-kjim-2016-423">
Department of Gastroenterology, Dankook University Hospital, Cheonan, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-kjim-2016-423">Correspondence to Hong Ja Kim, M.D. Tel: +82-41-550-3917 Fax: +82-41-556-3256 E-mail: <email>hjkimjung@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2017</year></pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>6</month>
<year>2017</year></pub-date>
<volume>32</volume>
<issue>4</issue>
<fpage>764</fpage>
<lpage>765</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>12</month>
<year>2016</year></date>
<date date-type="rev-recd">
<day>20</day>
<month>01</month>
<year>2017</year></date>
<date date-type="accepted">
<day>31</day>
<month>01</month>
<year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 The Korean Association of Internal Medicine</copyright-statement>
<copyright-year>2017</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
</article-meta></front>
<body>
<p>A 61-year-old woman presented to the hospital with a 2-month history of a tender nodule on the umbilicus and an 1-week history of icteric sclera. Her vital signs were within normal ranges. On physical examination, we noted an 1-cm sized, hard and painful nodule on the umbilicus without swelling (<xref rid="f1-kjim-2016-423" ref-type="fig">Fig. 1A</xref>). The laboratory test showed the following findings: hemoglobin 11.4 g/dL, aspartate aminotransferase 123 U/L, alanine transaminase 74 U/L, total bilirubin 12.98 mg/dL, C-reactive protein 2.29 mg/dL, and alkaline phosphatase 477 IU/L. Cancer antigen 19-9 level was 3,880 U/mL. Abdominopelvic computed tomography showed a 7.4 &#x000d7; 5.9 &#x000d7; 5.4 cm sized intrahepatic mass arising from the fundus of the gallbladder, multiple enlarged abdominal lymph nodes, enhancing seeding nodules in the peritoneum and focal umbilical thickening with enhancement (<xref rid="f1-kjim-2016-423" ref-type="fig">Fig. 1B</xref> and <xref rid="f1-kjim-2016-423" ref-type="fig">1C</xref>). Ultrasound-guided needle aspiration cytologic examination of the intrahepatic mass confirmed the diagnosis of adenocarcinoma of the gallbladder (<xref rid="f2-kjim-2016-423" ref-type="fig">Fig. 2A</xref>). The result of skin biopsy of the umbilicus was compatible with metastatic adenocarcinoma (<xref rid="f2-kjim-2016-423" ref-type="fig">Fig. 2B</xref> and <xref rid="f2-kjim-2016-423" ref-type="fig">2C</xref>). Her malignancy was judged to be inoperable due to the extent of the disease. A biliary stent was inserted to relieve jaundice. Palliative chemotherapy (cisplatin &#x0002b; gemcitabine) every 3 weeks was started.</p>
<p>Sister Mary Joseph nodule, an umbilical metastatic nodule, is reportedly present in 1% to 3% of all intra-abdominal and/or pelvic malignancies. The most common primary source is gastric carcinoma in men and ovarian carcinoma in women. Although Sister Mary Joseph nodule is unusual in a cancerous condition, this case suggests that Sister Mary Joseph nodule can be a crucial initial manifestation of widespread gallbladder cancer, and therefore, careful physical examination is necessary.</p>
</body>
<back>
<fn-group>
<fn fn-type="conflict"><p>No potential conflict of interest relevant to this article was reported.</p></fn>
</fn-group>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="f1-kjim-2016-423" position="float">
<label>Figure 1.</label><caption><p>(A) A hard, tender, and slightly bulging erythematous nodule without discharge or surface ulceration within the umbilicus, (B) abdominopelvic computed tomography showing an intrahepatic mass originating from the gallbladder and peritoneal seeding nodules, (C) and focal umbilical thickening with enhancement.</p></caption>
<graphic xlink:href="kjim-2016-423f1.tif"/>
</fig>
<fig id="f2-kjim-2016-423" position="float">
<label>Figure 2.</label><caption><p>(A) Microphotograph shows adenocarcinoma cells in the liver (H&amp;E, &#x000D7;400), (B) histopathology of the skin over the umbilical area is compatible with infiltration of adenocarcinoma cells (H&amp;E, &#x000D7;200), and (C) cytokeratin 7 positivity (&#x000D7;200).</p></caption>
<graphic xlink:href="kjim-2016-423f2.tif"/>
</fig>
</sec>
</back></article>